Zydus to Launch Semaglutide in India with Adjustable Pen Device
Zydus Lifesciences plans to launch semaglutide injections in India under brands Semaglyn, Mashema, and Alterme after patent expiry, featuring an innovative adjustable pen for diabetes and obesity treatment.


